Julia Kronberger, BSc MSc
Wintersemester 2023
321113 PR Arzneistoffsynthese - B7 - Zusatzkurse - (3 Kurse)
1 - 2 von 2
1
Guarrochena, X., Kronberger, J., Tieber, M., Ciesielski, P., Mindt, T. L., & Feiner, I. V. J. (2024). Straightforward Synthesis of DFO* - An Octadentate Chelator for Zirconium-89. ChemMedChem, 19(3), [e202300495]. https://doi.org/10.1002/cmdc.202300495
Fuchs, V., Cseh, K., Hejl, M., Vician, P., Neuditschko, B., Meier-Menches, S. M., Janker, L., Bileck, A., Gajic, N., Kronberger, J., Schaier, M., Neumayer, S., Koellensperger, G., Gerner, C., Berger, W., Jakupec, M. A., Malarek, M. S., & Keppler, B. K. (2023). Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in Mice. Chemistry: A European Journal, 29(4), [e202202648]. https://doi.org/10.1002/chem.202202648
1 - 2 von 2
1
Evaluation of two albumin-targeting moieties as in situ binders in comparison to maleimide
Anja Federa (Vortragende*r), H. Schueffl (Autor*in), Alexander Kastner (Autor*in), Julia Kronberger (Autor*in), Bernhard Keppler (Autor*in), Thomas Mindt (Autor*in), P. Heffeter (Autor*in) & Christian Kowol (Autor*in)
3 Sep. 2023
Aktivität: Vorträge › Vortrag › Science to Science
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Vortragende*r), Thomas Mindt (Autor*in), Elisabeth de Vries (Autor*in) & Marie Brandt (Autor*in)
12 Mai 2022
Aktivität: Vorträge › Vortrag › Science to Science
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Vortragende*r), E. de Vries (Autor*in), Marie Brandt (Autor*in) & Thomas Mindt (Autor*in)
5 Nov. 2021
Aktivität: Vorträge › Vortrag › Science to Science